Top

International Journal for Equity in Health

Published in:

Open Access 01-12-2019 | Care | Letter to the Editor

Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018

Authors: Brigg Reilley, Matt Miller, Matt Hudson, Rick Haverkate, Jessica Leston

Published in: International Journal for Equity in Health | Issue 1/2019

Abstract

Medicaid, the state-level public insurance in the United States, has widely differing criteria treatment for hepatitis C virus (HCV) such as stage of liver fibrosis, documented sobriety, and specialist consultation. In a rural health network, facilities located in two less restrictive states prescribed HCV drugs at a significantly higher rate than two more restrictive states (rate ratio 4.7, CI 2.6–8.5). Prescription rates per population were highly associated with HCV treatment policies.

Centers for Disease Control and Prevention, Hepatitis C factsheet https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm#section1, Accessed 1 Oct 2019.

Ly KN, Hughes EM, Jiles RB, Holmberg SD. Rising mortality associated with hepatitis C virus in the United States, 2003–2013. Clin Infect Dis. 2016;62(10):1287–8.CrossRef

World Health Organization, Hepatitis C fact sheet, https://www.who.int/news-room/fact-sheets/detail/hepatitis-c, Accessed 1 Oct 2019.

van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308(24):2584–93.CrossRef

Backus LI, Belperio PS, Shahoumian TA, Mole LA. Direct-acting antiviral sustained virologic response: impact on mortality in patients without advanced liver disease. Hepatology. 2018;68(3):827–38.CrossRef

Ward JW, Mermin JH. Simple, effective, but out of reach? Public health implications of HCV drugs. NEJM. 2015:2678–80.CrossRef

Centers for Disease Control and Prevention, Surveillance for Viral Hepatitis, US, 2017 https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm, Accessed 1 Oct 2019.

Reilley, B, Leston J, Doshani M, et. al. Assessing disparities in the rates of HCV diagnoses within American Indian or Alaska native populations served by the US Indian Health Service, 2005–2015. J Community Health 43, no. 6 (2018): 1115–1118.CrossRef

National Viral Hepatitis Roundtable, Center for Health Law and Policy Innovation, Harvard University, State of Hepatitis Medicaid Access,, stateofhepc.org, Accessed 1 July 2019.

10.

American Association for the Study of Liver Diseases and the Infectious Disease Society of America, When and in Whom to Initiate HCV Treatment, https://www.hcvguidelines.org/evaluate/when-whom, Accessed 2 Oct 2019.

Title: Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018
Authors: Brigg Reilley
Matt Miller
Matt Hudson
Rick Haverkate
Jessica Leston
Publication date: 01-12-2019
Publisher: BioMed Central
Keywords: Care
Hepatitis C
Published in: International Journal for Equity in Health / Issue 1/2019
Electronic ISSN: 1475-9276
DOI: https://doi.org/10.1186/s12939-019-1101-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Experiences, perspectives and values of Indigenous peoples regarding kidney transplantation: systematic review and thematic synthesis of qualitative studies

Impact of oral health on Australian urban Aboriginal and Torres Strait Islander families: a qualitative study

Socioeconomic inequalities in maternal health care utilization in Ghana

Socio-economic inequality in malnutrition among children in India: an analysis of 640 districts from National Family Health Survey (2015–16)

Long-term trends in smoking prevalence and its socioeconomic inequalities in Korea, 1992–2016

Centering female agency while investigating contraceptive use: a case study in Agincourt, South Africa